Trabeculectomy with large area mitomycin-C application as a first-line treatment in advanced glaucoma: Retrospective review

International Journal of Ophthalmology

Volumn 7, Issue 1, 2013, Pages 104-109

  Aktas, Zeynep ^a   Korkmaz, Safak ^b   Hasanreisoglu, Murat ^a   Onol, Merih ^c   Hasanreisoglu, Berati ^a  

^a GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^b Duzce Ataturk State Hospital   (Turkey)

^c Wold Eye Hospital   (Turkey)

Author keywords

Advanced glaucoma; Large area mitomycin C application; Trabeculectomy

Indexed keywords

EID: 84896440811     PISSN: 22223959     EISSN: 22274898     Source Type: Journal    
DOI: 10.3980/j.issn.2222-3959.2014.01.19     Document Type: Article

References (26)

1. Cairns JE. Trabeculectomy. Preliminary report of a new method. Am J Ophthalmol. 1968;66(4):673-679. [PubMed]
2. Shigeeda T, Tomidokoro A, Chen YN, Shirato S, Araie M. Long term follow up of initial trabeculectomy with mitomycin C for primary open angle glaucoma in Japanese patients. J Glaucoma. 2006;15(3):195-199. [PubMed]
3. Vesti E, Raitta C. A review of the outcome of trabeculectomy in open angle glaucoma. Ophthalmic Surg Lasers. 1997;28(2):128-132. [PubMed]
4. Aggarwal SP, Hendeles S. Risk of sudden visual loss following trabeculectomy in advanced primary open angle glaucoma. Br J Ophthalmol. 1986;70(2):97-99. [PMC free article] [PubMed]
5. Hesse RJ. Risk of sudden visual loss after filtration surgery in end-stage glaucoma. Am J Ophthalmol. 2006;141(5):983-984. [PubMed]
6. Broadway DC, Grierson I, O'Brien C, Hitchings RA. Adverse effects of topical antiglaucoma medication. I. The conjunctival cell profile. Arch Ophthalmol. 1994;112(11):1437-1445. [PubMed]
7. Broadway DC, Grierson I, O'Brien C, Hitchings RA. Adverse effects of topical antiglaucoma medication. II. The outcome of filtration surgery. Arch Ophthalmol. 1994;112(11):1446-1454. [PubMed]
8. Lavin MJ, Wormald RPL, Migdal CS, Hitchings RA. The influence of prior therapy on the success of trabeculectomy. Arch Ophthalmol. 1990;108(11):1543- 1548. [PubMed]
9. Smith RJ. Medical versus surgical therapy in glaucoma simplex. Br J Ophthalmol. 1972;56(3):277-283. [PMC free article] [PubMed]
10. Jay JL, Murray SB. Early trabeculectomy versus conventional management in primary open angle glaucoma. Br J Ophthalmol. 1988;72(12):881-889. [PMC free article] [PubMed]
11. Migdal C, Gregory W, Hitchings R. Long-term functional outcome after early surgery compared with laser and medicine in open-angle glaucoma. Ophthalmology. 1994;101(10):1651-1656; discussion 1657. [PubMed]
12. Musch DC, Gillespie BW, Lichter PR, Niziol LM, Janz NK, CIGTS Study Investigators Visual field progression in the Collaborative Initial Glaucoma Treatment Study the impact of treatment and other baseline factors. Ophthalmology. 2009;116(2):200-207. [PMC free article] [PubMed]
13. Onol M, Akta Z, Hasanreisoglu B. Enhancement of the success rate in trabeculectomy: large-area mitomycin-C application. Clin Experiment Ophthalmol. 2008;36(4):316-322. [PubMed]
14. Skuta GL, Parrish RK., 2nd Wound healing in glaucoma filtering surgery. Surv Ophthalmol. 1987;32(3):149-170. [PubMed]
15. Baudouin C, Pisella PJ, Fillacier K, Goldschild M, Becquet F, De Saint Jean M, Béchetoille A. Ocular surface inflammatory changes induced by topical antiglaucoma drugs: human and animal studies. Ophthalmology. 1999;106(3):556-563. [PubMed]
16. Feldman RM, Gross RL, Spaeth GL, Steinmann WC, Varma R, Katz LJ, Wilson RP, Moster MR, Spiegel D. Risk factors for the development of Tenon's capsule cysts after trabeculectomy. Ophthalmology. 1989;96(3):336-341. [PubMed]
17. Mikelberg FS, Schulzer M, Drance SM, Lau W. The rate of progression of scotomas in glaucoma. Am J Ophthalmol. 1986;101(1):1-6. [PubMed]
18. Wilson R, Walker AM, Dueker DK, Crick RP. Risk factors for rate of progression of glaucomatous visual field loss: a computer-based analysis. Arch Ophthalmol. 1982;100(5):737-741. [PubMed]
19. Kooner KS, AlBdoor M, Cho BJ, Adams-Huet B. Risk factors for progression to blindness in high tension primary open angle glaucoma: comparison of blind and nonblind subjects. Clin Ophthalmol. 2008;2(4):757-762. [PMC free article] [PubMed]
20. Flach AJ. Does medical treatment influence the success of trabeculectomy? Trans Am Ophthalmol Soc. 2004;102:219-223; discussion 223-224. [PMC free article] [PubMed]
21. Lichter PR, Musch DC, Gillespie BW, Guire KE, Janz NK, Wren PA, Mills RP, CIGTS Study Group Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology. 2001;108(11):1943-1953. [PubMed]
22. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. The AGIS Investigators. Am J Ophthalmol. 2000;130(4):429-440. [PubMed]
23. Costa VP, Smith M, Spaeth GL, Gandham S, Markovitz B. Loss of visual acuity after trabeculectomy. Ophthalmology. 1993;100(5):599-612. [PubMed]
24. Francis BA, Singh K, Lin SC, Hodapp E, Jampel HD, Samples JR, Smith SD. Novel glaucom a procedures: a report by the American Academy of Ophthalmology. Ophthalmology. 2011;118(7):1466-1480. [PubMed]
25. Khaw PT, Chiang M, Shah P, Sii F, Lockwood A, Khalili A. Enhanced trabeculectomy: the moorfields safer surgery system. Dev Ophthalmol. 2012;50:1-28. [PubMed]
26. Dhingra S, Khaw PT. The moorfields safer surgery system. Middle East Afr J Ophthalmol. 2009;16(3):112-115. [PMC free article] [PubMed]